Beacon Therapeutics

Beacon Therapeutics is a clinical-stage ophthalmic gene therapy company founded in 2023 to save and restore the sight of people living with rare and prevalent retinal diseases that lead to blindness. Built around adeno-associated virus (AAV) gene therapy, the company delivers functional copies of mutated genes into retinal cells so the body can produce the missing therapeutic protein. Its lead clinical program, laru-zova (laruparetigene zovaparvovec), targets X-linked retinitis pigmentosa (XLRP), alongside preclinical programs in dry age-related macular degeneration (dAMD) and cone-rod dystrophy (CRD), the latter in-licensed from the University of Oxford. Beacon operates across the United Kingdom and the United States, with a corporate base in London and a US presence in the Cambridge, Massachusetts area. It is a therapeutics developer, not a software or data platform company, and publishes no public API, SDK or developer program.

Beacon Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Therapy, Ophthalmology, and Clinical Trials.

Beacon Therapeutics’ developer surface includes engineering blog and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub

8.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyGene TherapyOphthalmologyClinical TrialsLife SciencesRare DiseasePharmaceuticals

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 8.3/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Commercial Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/beacon-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 5

The organization behind the API

Website

About

Blog

BlogRSS

Careers

Source (apis.yml)

aid: beacon-therapeutics
name: Beacon Therapeutics
description: Beacon Therapeutics is a clinical-stage ophthalmic gene therapy company founded in 2023 to save and restore the
  sight of people living with rare and prevalent retinal diseases that lead to blindness. Built around adeno-associated virus
  (AAV) gene therapy, the company delivers functional copies of mutated genes into retinal cells so the body can produce the
  missing therapeutic protein. Its lead clinical program, laru-zova (laruparetigene zovaparvovec), targets X-linked retinitis
  pigmentosa (XLRP), alongside preclinical programs in dry age-related macular degeneration (dAMD) and cone-rod dystrophy
  (CRD), the latter in-licensed from the University of Oxford. Beacon operates across the United Kingdom and the United States,
  with a corporate base in London and a US presence in the Cambridge, Massachusetts area. It is a therapeutics developer,
  not a software or data platform company, and publishes no public API, SDK or developer program.
image: https://www.beacontx.com/wp-content/themes/beacon/assets/images/favicon/apple-touch-icon.png
url: https://raw.githubusercontent.com/api-evangelist/beacon-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Gene Therapy
- Ophthalmology
- Clinical Trials
- Life Sciences
- Rare Disease
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.beacontx.com/
- type: About
  url: https://www.beacontx.com/about-us/
- type: Blog
  url: https://www.beacontx.com/news-and-events/
- type: BlogRSS
  url: https://www.beacontx.com/feed/
- type: Contact
  url: https://www.beacontx.com/contact/
- type: PrivacyPolicy
  url: https://www.beacontx.com/privacy-statement/
- type: Careers
  url: https://www.beacontx.com/careers/
- type: DomainSecurity
  url: security/beacon-therapeutics-domain-security.yml
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Beacon Therapeutics is a clinical-stage AAV gene therapy developer whose entire public surface is a 14-page WordPress
    marketing site (pipeline, clinical trials, disease focus, careers) — /developers, /api, /openapi.json, /llms.txt and every
    /.well-known/ path return a hard 404, and the product is a retinal therapeutic, not software.
  evidence:
  - url: https://www.beacontx.com/developers
    status: 404
  - url: https://www.beacontx.com/openapi.json
    status: 404
  - url: https://www.beacontx.com/.well-known/agent-card.json
    status: 404
  - url: https://www.beacontx.com/.well-known/security.txt
    status: 404
  - url: https://www.beacontx.com/llms.txt
    status: 404
  - url: https://www.beacontx.com/sitemap_index.xml
    status: 200
  checked: '2026-08-06'